Stratos Wealth Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Stratos Wealth Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2	Closed	-$12K	–	1253
2021 Q2	$12K	Buy	+2	New	+$12.9K	﹤0.01%	1182

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Stratos Wealth Partners's TTOO Position: Q3 2021 in Review

Stratos Wealth Partners sold out of T2 Biosystems, Inc (TTOO) in Q3 2021, closing a stake of 2 shares — an estimated $12K sold.

Stratos Wealth Partners first reported a position in TTOO in Q2 2021 and held it in 1 quarter. The position peaked at $12K in Q2 2021. 73 funds tracked by Wall St. Rank hold TTOO as of Q3 2021.

Stratos Wealth Partners reported no remaining T2 Biosystems, Inc position as of Q3 2021 after selling out during the quarter.
Stratos Wealth Partners sold 2 T2 Biosystems, Inc shares in Q3 2021, an estimated $12K.
Stratos Wealth Partners first reported a position in T2 Biosystems, Inc in Q2 2021 and held it in 1 quarter.
Stratos Wealth Partners's T2 Biosystems, Inc position peaked at $12K in Q2 2021.
73 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2021.

Based on Stratos Wealth Partners's 13F filing for Q3 2021, filed 19 Oct 2021.